Cutter Capital Management »

Bridgebio Pharma shares owned by Cutter Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Cutter Capital Management from 13F filings

Historical chart of Cutter Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Cutter Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Cutter Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.2M 103k 40.37

More positions owned by Cutter Capital Management

Amgen (AMGN)
Merck & Co (MRK)
Amicus Therapeutics (FOLD)
Insmed Com Par $.01 (INSM)
BioMarin Pharmaceutical (BMRN)
Roivant Sciences SHS (ROIV)
Exelixis (EXEL)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Royalty Pharma Shs Class A (RPRX)
ACADIA Pharmaceuticals (ACAD)
BioCryst Pharmaceuticals (BCRX)
Halozyme Therapeutics (HALO)
Perrigo SHS (PRGO)
Pfizer (PFE)
Bristol Myers Squibb (BMY)

View all positions for Cutter Capital Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma